JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
CALL
Duke Energy
DUK
$88.8B
| $10.5M | ﹤0.01% |
109,100
+5,900
| +6% | +$583K |
2017 Q1
24 quarters
|
|
2152
Vishay Intertechnology
VSH
$5.69B
| $10.5M | ﹤0.01% |
464,392
+99,904
| +27% | +$2.2M |
2013 Q2
39 quarters
|
|
2153
Arcos Dorados Holdings
ARCO
$1.71B
| $10.5M | ﹤0.01% |
1,361,762
-59,390
| -4% | -$488K |
2019 Q3
14 quarters
|
|
2154
EnerSys
ENS
$6.96B
| $10.5M | ﹤0.01% |
120,770
+29,481
| +32% | +$2.48M |
2013 Q2
39 quarters
|
|
2155
Merit Medical Systems
MMSI
$5.2B
| $10.5M | ﹤0.01% |
141,828
+19,897
| +16% | +$1.4M |
2016 Q2
27 quarters
|
|
|
SWTX
2156
DELISTED
SpringWorks Therapeutics
SWTX
| $10.5M | ﹤0.01% |
407,108
-42,819
| -10% | -$1.25M |
2019 Q4
13 quarters
|
|
2157
Abercrombie & Fitch
ANF
$6B
| $10.5M | ﹤0.01% |
377,431
+105,479
| +39% | +$2.94M |
2013 Q2
39 quarters
|
|
|
UPWD
2158
DELISTED
JPMorgan Social Advancement ETF
UPWD
| $10.5M | ﹤0.01% |
200,000
| – | – |
2022 Q3
2 quarters
|
|
2159
PUT
Applied Materials
AMAT
$430B
| $10.5M | ﹤0.01% |
85,200
-85,800
| -50% | -$9.85M |
2018 Q4
17 quarters
|
|
|
RRAC
2160
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $10.5M | ﹤0.01% |
+1,000,000
| New | +$10.4M |
2023 Q1
0 quarters
|
|
2161
Cohen & Steers
CNS
$3.75B
| $10.4M | ﹤0.01% |
163,352
+14,257
| +10% | +$994K |
2015 Q4
29 quarters
|
|
|
NUVA
2162
DELISTED
NuVasive, Inc.
NUVA
| $10.4M | ﹤0.01% |
252,220
-1,821,217
| -88% | -$77.9M |
2013 Q2
39 quarters
|
|
2163
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.02B
| $10.4M | ﹤0.01% |
174,317
+9,477
| +6% | +$550K |
2022 Q3
2 quarters
|
|
|
P
2164
PUT
Everpure Inc
P
$47.9B
| $10.4M | ﹤0.01% |
406,700
-705,700
| -63% | -$19M |
2022 Q2
3 quarters
|
|
|
CIRC
2165
DELISTED
JPMorgan Sustainable Consumption ETF
CIRC
| $10.4M | ﹤0.01% |
200,000
| – | – |
2022 Q3
2 quarters
|
|
2166
MarineMax
HZO
$1.16B
| $10.4M | ﹤0.01% |
360,694
+29,441
| +9% | +$926K |
2017 Q4
21 quarters
|
|
2167
CALL
Gilead Sciences
GILD
$179B
| $10.3M | ﹤0.01% |
124,700
-29,300
| -19% | -$2.43M |
2014 Q3
34 quarters
|
|
2168
PUT
Biogen
BIIB
$33B
| $10.3M | ﹤0.01% |
37,200
-35,900
| -49% | -$9.93M |
2020 Q4
9 quarters
|
|
2169
Weatherford International
WFRD
$5.89B
| $10.3M | ﹤0.01% |
173,996
+13,615
| +8% | +$797K |
2021 Q2
7 quarters
|
|
2170
AZZ Inc
AZZ
$4.18B
| $10.3M | ﹤0.01% |
250,074
+44,338
| +22% | +$1.82M |
2014 Q4
33 quarters
|
|
2171
CALL
Johnson & Johnson
JNJ
$610B
| $10.3M | ﹤0.01% |
66,300
-258,800
| -80% | -$41.8M |
2014 Q3
34 quarters
|
|
|
LTHM
2172
DELISTED
Livent Corporation
LTHM
| $10.3M | ﹤0.01% |
473,113
-11,897
| -2% | -$275K |
2018 Q4
17 quarters
|
|
2173
iShares Intermediate Government/Credit Bond ETF
GVI
$3.73B
| $10.3M | ﹤0.01% |
98,301
+11,992
| +14% | +$1.24M |
2013 Q2
39 quarters
|
|
|
AY
2174
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $10.2M | ﹤0.01% |
346,549
-74,101
| -18% | -$2.01M |
2015 Q3
30 quarters
|
|
2175
Barclays
BCS
$78.7B
| $10.2M | ﹤0.01% |
1,424,498
+623,939
| +78% | +$5.16M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.